Thoracic Surgery (Cardiothoracic Vascular Surgery) Doctors in Burlington, MA Accepting Medicare

8 Thoracic Surgery (Cardiothoracic Vascular Surgery) doctors found. Showing 1 - 8

Dr. Elliot Louis Servais, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd, Lahey Hospital And Medical Center, Burlington, MA 01805 Phone: 781-744-8570

Dr. Susan D. Moffatt-bruce, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-8000

Cameron T. Stock, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Road Lahey Hospital And Medical Center, Burlington, MA 01805 Phone: 781-744-8022    Fax: 781-744-5359

Siva K Patimalla Venkata, Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-8000

Prem Shekar, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-8000

Richard S D'agostino, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: Lahey Clinic, 41 Mall Road, Burlington, MA 01805 Phone: 781-744-8000

Dr. Saqib Masroor, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-8000

Christina Williamson, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: Lahey Clinic, 41 Mall Rd., Burlington, MA 01805 Phone: 781-744-8481    Fax: 781-744-8812

News Archive

Some benefits from prescription drug DTCA, but significant risks remain

While the debate over prescription drug advertising persists, a new study released online in the American Journal of Public Health offers guidelines for improving drug ads in order to minimize potential harm and maximize benefits. The study reveals that while there are some benefits from prescription drug direct-to-consumer advertising (DTCA), there are significant risks that are magnified by the prominence of DTCA.

GSK receives FDA approval for Lamictal XR to treat partial seizures

GlaxoSmithKline announced today that the U.S. Food and Drug Administration has approved Lamictal XR Extended-Release Tablets for conversion to monotherapy in patients 13 years and older with partial seizures taking one anti-epileptic drug.

New microneedle patches for delivery of psychedelic pharmaceuticals

Although one may think of psychedelic pharmaceuticals as being dangerous and detrimental, scientists have been conducting experiments and clinical trials on some of them and have obtained positive results when testing them for medical use.

Armetheon reaches agreement with FDA on SPA for final pivotal trial of tecarfarin

Armetheon, Inc., today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the final pivotal trial of tecarfarin.

Millennium, Seattle Genetics commence ADCETRIS plus chemotherapy phase III trial in MTCL

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas.

Read more Medical News

› Verified 5 days ago